Quantitative proteomic analysis reveals that lipopolysaccharide induces mitogen-activated protein kinase-dependent

Kyunghee Byun1, Jin Young Kim, Enkhjargal Bayarsaikhan

  • 1Center for Genomics and Proteomics, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Korea.

Electrophoresis
|November 20, 2012
PubMed

Insights

Lipopolysaccharide (LPS) activates human microglial cells, upregulating mitogen-activated protein kinase (MAPK) signaling pathways. This study identifies key protein changes, including CMPK1, crucial for inflammatory responses in the central nervous system.

Area of Science:

  • Neuroscience
  • Immunology
  • Proteomics

Background:

  • Microglial cells are key immune defenders in the central nervous system.
  • Lipopolysaccharide (LPS) stimulation triggers inflammatory gene expression in microglia, relevant to neurodegenerative diseases.

Purpose of the Study:

  • To systematically analyze proteomic changes in human microglial cells upon LPS activation.
  • To identify key signaling pathways involved in LPS-induced microglial inflammatory responses.

Main Methods:

  • Quantitative proteomics using tandem mass tags (TMT) and 2D-nano LC-ESI-MS/MS.
  • Immunohistochemistry and Western blotting to validate protein expression.
  • High-content screening to assess nuclear translocation of transcription factors.

Main Results:

  • LPS stimulation altered the expression of 21 proteins in human microglial cells.
  • CMPK1, a mitogen-activated protein kinase (MAPK) regulator, was significantly upregulated.
  • MAPK pathways (ERK1/2, p38, SAPK/JNK) and NFκB activation were confirmed.

Conclusions:

  • MAPK signaling is critically involved in LPS-induced human microglial activation.
  • Understanding these pathways offers insights into neuroinflammation and neurodegenerative disease mechanisms.